Comparative study of adjuvants for allergen-specific immunotherapy in a murine model

被引：12
|
作者：
Vazquez de la Torre, Maria [1 ]
Luisa Baeza, Maria [2 ,3 ,4 ]
Najera, Laura [5 ]
Manuel Zubeldia, Jose [2 ,3 ,4 ]
机构：
[1] Infanta Leonor Univ Hosp, Allergy Serv, Madrid, Spain
[2] Gregorio Maranon Univ Gen Hosp, Allergy Serv, Madrid, Spain
[3] Biomed Res Network Rare Dis CIBERER U761, Madrid, Spain
[4] Gregorio Maranon Hlth Res Inst, Madrid, Spain
[5] Puerta Hierro Majadahonda Univ Hosp, Patol Serv, Madrid, Spain
来源：
IMMUNOTHERAPY | 2018年 / 10卷 / 14期
关键词：
adjuvants; allergen-specific immunotherapy; allergic asthma; aluminum hydroxide; calcium phosphate; immunostimulatory sequences; monophosphoryl lipid A; murine model; INDUCED AIRWAY INFLAMMATION; IGE ANTIBODY-FORMATION; CPG OLIGODEOXYNUCLEOTIDES; IMMUNE-RESPONSE; IMMUNOSTIMULATORY DNA; EXPERIMENTAL ASTHMA; TH1; RESPONSES; MICE; HYPERRESPONSIVENESS; INDUCTION;
D O I：
10.2217/imt-2018-0072
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Aim: To compare the immunological and clinical changes induced by allergen-specific immunotherapy (AIT) using different adjuvants. Materials & methods:Olea europaea pollen-sensitized mice were treated with olea plus aluminum hydroxide, calcium phosphate, monophosphoryl lipid A (MPL) or immunostimulatory sequences (ISS). Results: Aluminum hydroxide seems to drive initially to a Th2-type response. Bacteria-derived adjuvants (MPL and ISS) skew the immune response toward Th1 and Treg pathways. Specific-IgE production was lower after AIT with MPL and ISS. Moreover, IgG2a production significantly increased in ISS-treated mice. Bacteria-derived adjuvants also improved the Th1 cytokine response due to IFN- higher secretion. In addition, they improved bronchial hyper-reactivity and lung inflammation. Conclusion: Bacteria-derived adjuvants may enhance the efficacy of AIT.
引用
收藏
页码：1219 / 1228
页数：10
相关论文
共 50 条
  • [1] Adjuvants in allergen-specific immunotherapy
    Klimek, L.
    Kramer, M.
    Pfaar, O.
    [J]. ALLERGOLOGIE, 2017, 40 (02) : 46 - 49
  • [2] Adjuvants in Allergen-Specific Immunotherapy
    Gajdanowicz, P.
    Pfaar, O.
    Jutel, M.
    [J]. ALLERGOLOGIE, 2018, 41 (09) : 427 - 434
  • [3] Perspectives in vaccine adjuvants for allergen-specific immunotherapy
    Fili, Lucia
    Cardilicchia, Elisa
    Maggi, Enrico
    Parronchi, Paola
    [J]. IMMUNOLOGY LETTERS, 2014, 161 (02) : 207 - 210
  • [4] Adjuvants and formulations for allergen-specific sublingual immunotherapy
    Van Overtvelt, L.
    Lombardi, V.
    Saint-Lu, N.
    Mascarell, L.
    Tourdot, S.
    Moingeon, P.
    [J]. REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE, 2008, 48 (03): : 127 - 129
  • [5] Novel vaccines and adjuvants for allergen-specific immunotherapy
    Crameri, Reto
    Rhyner, Claudio
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (06) : 761 - 768
  • [6] Allergen-specific immunotherapy: Power of adjuvants and novel predictive biomarkers
    Sokolowska, Milena
    Boonpiyathad, Tadech
    Escribese, Maria M.
    Barber, Domingo
    [J]. ALLERGY, 2019, 74 (11) : 2061 - 2063
  • [7] Adjuvants in Allergen-Specific Immunotherapy: Modulating and Enhancing the Immune Response
    Zubeldia, J. M.
    Ferrer, M.
    Davila, I
    Justicia, J. L.
    [J]. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (02) : 103 - 111
  • [8] New and old adjuvants in allergen-specific immunotherapy: With a focus on nanoparticles
    Feng, Zhongtao
    Yi, Xin
    Hajavi, Jafar
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (02) : 863 - 876
  • [9] Allergen-specific immunotherapy
    Treudler, R.
    Pfuetzner, W.
    [J]. HAUTARZT, 2021, 72 (09): : 749 - 750
  • [10] Allergen-Specific Immunotherapy
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1520): : 79 - 80
12345